Skip to main content

WEBINAR: Ziccum; The generation of temperature stable dry powder vaccine, using a new unit operation for the vaccine industry, LaminarPace

May 3, 2021Webex
Webinar: Ziccum; The generation of temperature stable dry powder vaccine, using a new unit operation for the vaccine industry, LaminarPace Prsenter Ziccum AB, Göran Conradson, Founder and CEO Abstract LaminarPace drying technology is a new unit operation for the fill and finish step of vaccine to stabilize delicate and sensitive vaccines. The process is built on air-drying, usingcounter-current flow with stream separation at room temperature.Liquid vaccines are driedinto a temperature stable powder at high yields, which subsequently can be quickly dissolved prior immunization. The unit operation will be described with examples and an outline to incorporate LaminarPace process intoa fill and finish manufacturing of vaccines will be presented. Recording

Attached documents